Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001193125-26-129154

Options or other derivatives

  • See Remarks acquired 219,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Simms Christopher Paul See Remarks 2026-03-25 Grant or award · Stock Option (Right to Buy) +219,000 219,000 D: show line 1 in the form
Loading xslF345X06/ownership.xml…